Vir Biotechnology, Inc.
VIR
$9.40
$0.111.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -125.70M | -42.92M | -163.14M | -110.96M | -120.97M |
| Total Depreciation and Amortization | 2.81M | 2.90M | 3.00M | 2.92M | 2.87M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.18M | 16.99M | 13.17M | 12.88M | 13.92M |
| Change in Net Operating Assets | -22.68M | -2.84M | -20.60M | -25.06M | 26.06M |
| Cash from Operations | -132.39M | -25.88M | -167.57M | -120.22M | -78.12M |
| Capital Expenditure | -390.00K | -348.00K | -317.00K | -2.54M | -1.63M |
| Sale of Property, Plant, and Equipment | -- | -110.00K | 37.00K | 45.00K | 281.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.23M | 87.11M | 40.73M | 58.95M | 128.17M |
| Cash from Investing | 11.84M | 86.65M | 40.45M | 56.46M | 126.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 162.52M | 1.04M | 101.00K | 2.41M | 598.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2.00K | 1.00K | -360.00K | -- |
| Cash from Financing | 162.52M | 1.04M | 102.00K | 2.05M | 598.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.97M | 61.81M | -127.02M | -61.72M | 49.30M |